Pyrrolidinone glucokinase activators
US7741327B2 · kind B2 · utility
1Cited by
1References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2009 |
| Grant date | Jun 22, 2010 |
| Priority date | — |
| Expiry date | Mar 9, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.